Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making

J Volavka, L Citrome - Expert opinion on pharmacotherapy, 2009 - Taylor & Francis
Background: Antipsychotic medications are conventionally divided into two groups: First-
generation and second-generation antipsychotics (FGAs and SGAs). There is a …
被引用次数：97 相关文章

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making.

J Volavka, L Citrome - Expert Opinion on Pharmacotherapy, 2009 - europepmc.org
Background Antipsychotic medications are conventionally divided into two groups: First-
generation and second-generation antipsychotics (FGAs and SGAs). There is a …

Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making

J Volavka, L Citrome - Expert opinion on …, 2009 - pubmed.ncbi.nlm.nih.gov
Background Antipsychotic medications are conventionally divided into two groups: First-
generation and second-generation antipsychotics (FGAs and SGAs). There is a …

Oral antipsychotics for the treatment of schizophrenia: Heterogeneity in efficacy and tolerability should drive decision-making

J Volavka, L Citrome - Expert Opinion on Pharmacotherapy, 2009 - hero.epa.gov
Background: Antipsychotic medications are conventionally divided into two groups: First-
generation and second-generation antipsychotics (FGAs and SGAs). There is a …